Hypercalcemia affects up to 30% of patients with cancer. 1 It has been seen in most cancers but is most common in patients with non-small cell lung cancer, breast cancer, multiple myeloma, head and ...
Hypercalcemia has been reported to occur in up to 30% of patients who have a malignancy. Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those ...
Paraneoplastic syndromes are rarely seen in gynecological tumors especially in endometrial cancer. Early identification of paraneoplastic syndromes plays a significant role in the treatment and ...
If calcium is elevated on a metabolic panel (usually done because the patient has hypertension or diabetes mellitus), I typically determine ionized calcium and parathyroid hormone (PTH) levels. If the ...
A real-world cohort study showed no difference in efficacy between denosumab and bisphosphonates in treating inpatients with hypercalcemia of malignancy. “Prospective randomized trials are warranted ...
Hypercalcemia has been reported to occur in up to 30% of patients who have a malignancy. Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results